News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Friday, July 21, 2017

Top Breaking News

News from Around the Web

Press Releases
Teligent Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
EU Regulators Give Nod to Advanced Accelerator Applications ' Med to Treat the Cancer That Killed Steve Jobs
Effective Immediately: AEterna Zentaris (AEZS) CEO Out And New Leader Named, Special Committee Formed To Review Options
Syros Pharma Publishes Foundational Data Supporting Ongoing Phase II Clinical Trial Of SY-1425 For Genomically Defined AML And MDS Patients
BioLogics Release: NERLYNX (Neratinib) Tablets Approved For HER2+ Breast Cancer In The Extended Adjuvant Setting
Relypsa (RLYP) Announces European Approval Of Veltassa To Treat Adult Patients With Hyperkalemia (Elevated Blood Potassium Levels)
Sunovion’s Latuda (Lurasidone HCI) Receives Health Canada Approval To Treat Adolescents With Schizophrenia
Vifor Pharma Release: European Commission (EC) Approves Marketing Authorisation For Veltassa
Lexicon Pharma (LXRX) Collaborator Ipsen (IPN.PA) Receives Positive CHMP Opinion For Xermelo (Telotristat Ethyl)
EMA's CHMP Recommends Approval For Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer
Novartis AG (NVS) Receives Positive CHMP Opinion For Rydapt (Midostaurin) For Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) And Three Types Of Advanced Systemic Mastocytosis (SM)
Sanofi (SNY) And Regeneron (REGN) Receive Positive CHMP Opinion For Dupixent (Dupilumab) To Treat Adult Patients With Moderate-To-Severe Atopic Dermatitis
AbbVie (ABBV) Receives CHMP Positive Opinion For HUMIRA (Adalimumab) For The Treatment Of Pediatric Patients With Chronic Non-Infectious Anterior Uveitis
Vanda (VNDA) Receives Negative Opinion For Marketing Authorization From The EMA On Fanaptum For The Treatment Of Schizophrenia
Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting From Dompe Research For The Treatment Of Moderate To Severe Neurotrophic Keratitis Is Made In Italy
Ipsen (IPN.PA) Receives Positive CHMP Opinion For Approval Of Xermelo (Telotristat Ethyl), For The Treatment Of Carcinoid Syndrome Diarrhea In Patients Inadequately Controlled By Somatostatin Analogue Therapy
GlaxoSmithKline (GSK) Submits EU Filing For Extended Use Of Relvar Ellipta In Patients With Controlled Asthma On An ICS/LABA Combination
Janssen-Cilag International NV (JNJ) Receives Positive CHMP Opinion For SYMTUZA The First Darunavir-Based Single-Tablet Regimen For The Treatment Of HIV
Merck KGaA (MKGAF.PK) Release: EMA's CHMP Issues Positive Opinion For Avelumab For The Treatment Of Metastatic Merkel Cell Carcinoma
Amgen (AMGN) Release: FDA Accepts Biologics License Application For Aimovig (erenumab)
FDA Accepts Biologics License Application For AMG 334 (Erenumab), An Important Regulatory Milestone For Novartis AG (NVS)
SillaJen And Lee's Pharmaceutical Announce Approval By The China CFDA To Commence Phase III Clinical Trial For Oncolytic Immunotherapy, Pexa-Vec, In Liver Cancer
uniQure (QURE) Announces The Successful Development And Scale-Up Of Manufacturing Processes For Its Hemophilia B Gene Therapy Program
Samumed Successfully Completes Phase I Study For Potential Topical Treatment For Chronic Tendinopathy
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA (C1 Esterase Inhibitor Subcutaneous [Human])
Fraunhofer Institute for Cell Therapy and Immunology IZI Release: Reading Spelling Errors In A Timely Manner: Laying The Foundations For Future Early Testing
IBM (IBM) And University of Alberta Publish New Data On Machine Learning Algorithms To Help Predict Schizophrenia
Onyx (AMGN) Helps Accelerate TopiVert’s Compounds To Clinic
Evaluate Release: Epi Analyzer: Blockbusters Out, Highly Targeted Therapies In
Merck & Co. (MRK) And Pfizer (PFE) Collaborate With Corning To Modernize Pharmaceutical Glass Packaging
Aptevo Therapeutics (APVO) And Alligator Bioscience Announce Plans To Co-Develop Novel Bispecific Antibody For Tumor-Directed Immunotherapy
New amfAR Research Grants Advance Gene Therapy And Other Innovative Approaches To HIV Cure
BrainStorm Cell Awarded $16 Million Non-Dilutive Grant From CIRM In Support Of Phase III Clinical Trial Of NurOwn In ALS
Aceto Subsidiary, Rising Pharma, Announces Product Launches
Genprex Files Registration Statement For Proposed Initial Public Offering
VANC Pharmaceuticals Announces Non Brokered Private Placement
Recro Pharma (REPH) Reports Inducement Grants For New Staff
Prime Therapeutics Urges Caution On Mandates Of Abuse-Deterrent Formulations Of Opioids Citing Value Concerns
SynbiCITE: Vibrant Synthetic Biology Ecosystem Has Developed In The UK – Promising New Jobs And Valuable Technology
miRagen To Ring The Nasdaq Stock Market Closing Bell
National Research Council of Canada And Lexaria Bioscience Corp. (LXRP) Commence Laboratory Work
Innocoll (INNL) Announcement Relating To The Outcome Of The Court Sanction Hearing
CloudLIMS.Com Adds Robust Multi-Analyte Testing Functionality To Its Cloud-based LIMS, CloudLIMS Lite
Amgen (AMGN) Announces Webcast Of 2017 Second Quarter Financial Results
ArQule (ARQL) To Report Second Quarter 2017 Financial Results On August 4, 2017
SAGE Therapeutics (SAGE) To Report Second Quarter 2017 Financial Results On Thursday, August 3, 2017
Alkermes (ALKS) To Host Conference Call To Discuss Second Quarter 2017 Financial Results
Ironwood (IRWD) To Host Second Quarter 2017 Investor Update Call
Infinity Pharma (INFI) Announces The Date Of Its Second Quarter 2017 Financial Results Conference Call And Webcast
Ligand (LGND) To Report Second Quarter 2017 Results On August 7th
Ophthotech (OPHT) To Report Second Quarter 2017 Financial Results And Host Conference Call On Wednesday, July 26, 2017
Omnicell (OMCL) To Release Second Quarter 2017 Earnings Results On July 27, 2017
TherapeuticsMD (TXMD) To Host Second Quarter Financial Results Conference Call And Webcast On August 3
Neurocrine (NBIX) Announces The Appointment Of Julie Cooke As Chief People Officer
VLP Therapeutics Appoints Jacob Licht As Chief Operating Officer
Crohn's & Colitis Foundation Launches New IBD Clinical Trials Community To Educate And Support Clinical Trial Participation
American Brain Tumor Association (ABTA) Statement Regarding Senator John Mccain's Glioblastoma (GBM) Diagnosis
Tissue Regenix Banks $52 Million and Pays $30 Million for Texas' CellRight
Amphora Medical Closes $35.5 Million Series B Financing
Aspect Imaging Wins FDA Approval for the First Neonatal Magnetic Resonance Imaging Device
Ypsomed (YPSN.SW) Tanks as Insulet (PODD) Decides Not to Extend Omnipod Agreement in 2018
TearLab (TEAR) Announces European Regulatory Clearance For Next-Generation Tearlab Discovery System
SpinalCyte, LLC Receives New Japanese Patent
Avacen Medical Release: Introduction Of New Concept In Wound-Healing Expected To Dramatically Reduce Amputations In India
OraSure Tech (OSUR) Receives World Health Organization Prequalification Of OraQuick HIV Self-Test
KD&A Release: Meeting Medical Software Regulatory Requirements
CRH Medical To Announce Unaudited Second Quarter Results On August 2, 2017
Cerus (CERS) To Release Second Quarter 2017 Results On August 3, 2017
IRIDEX (IRIX) To Report Second Quarter 2017 Financial Results On August 3, 2017
Quotient Limited (QTNTU) To Report Continued Progress On The Commercial Scale-Up Of Mosaiq And Fiscal First Quarter 2018 Financial Results And Host Conference Call
Second Sight (EYES) To Discuss Second Quarter 2017 Financial Results On August 1, 2017 Conference Call
Teresa L. Kline Joins Intersect ENT’s Board Of Directors